Silco Pharmaceuticals Limited (DSE: SILCOPHL)

Silco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	1,920	2,533	2,741	2,709	2,325	2,322
Market Cap Growth	-18.80%	-7.58%	1.15%	16.52%	0.16%	-
Enterprise Value	1,869	2,491	2,643	2,599	2,064	2,310
Last Close Price	18.50	24.09	25.50	24.25	19.90	19.75
PE Ratio	45.23	36.12	31.35	29.73	24.84	9.79
PS Ratio	4.58	5.45	4.90	4.51	3.17	2.53
PB Ratio	0.84	1.09	1.20	1.19	1.04	1.06
P/FCF Ratio	56.51	-1725.76	43.53	-22.73	-99.18	439.89
P/OCF Ratio	20.27	14.03	16.21	10.53	15.86	28.74
EV/Sales Ratio	4.43	5.36	4.72	4.32	2.81	2.51
EV/EBITDA Ratio	12.02	16.19	15.35	16.88	11.75	10.32
EV/EBIT Ratio	33.39	37.09	27.11	32.74	21.29	16.33
EV/FCF Ratio	54.99	-1697.54	41.99	-21.80	-88.03	437.72
Debt / Equity Ratio	0.00	-	0.00	0.00	-	-
Debt / EBITDA Ratio	0.07	-	0.02	0.05	-	-
Debt / FCF Ratio	0.31	-	0.07	-0.07	-	-
Asset Turnover	0.15	0.17	0.21	0.22	0.28	0.39
Inventory Turnover	0.66	0.71	0.82	0.96	1.18	1.55
Quick Ratio	1.57	1.44	1.56	1.64	2.86	3.32
Current Ratio	3.48	3.40	3.61	3.72	5.10	5.56
Return on Equity (ROE)	1.83%	3.01%	3.71%	3.75%	3.76%	8.28%
Return on Assets (ROA)	1.25%	1.53%	2.25%	1.85%	2.32%	3.75%
Return on Capital (ROIC)	1.50%	1.82%	2.67%	2.19%	2.74%	4.51%
Earnings Yield	2.21%	2.73%	3.08%	3.12%	3.58%	7.00%
FCF Yield	1.77%	-0.06%	2.30%	-4.40%	-1.01%	0.23%
Dividend Yield	1.62%	1.25%	1.96%	4.12%	5.03%	0.92%
Payout Ratio	45.32%	45.43%	74.15%	73.25%	22.11%	-
Buyback Yield / Dilution	-1.20%	-	-	-	-28.88%	-13.76%
Total Shareholder Return	0.42%	1.25%	1.96%	4.12%	-23.85%	-12.83%

Source: S&P Capital IQ. Standard template. Financial Sources.